Cargando…
Non-responder migraine patients to a first anti-CGRP monoclonal antibody benefit from a switch to a second one
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Viguera Editores (Evidenze Group)
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364061/ https://www.ncbi.nlm.nih.gov/pubmed/36908035 http://dx.doi.org/10.33588/rn.7606.2022350 |
| _version_ | 1785076772660838400 |
|---|---|
| author | Fresán-Restituto, Daniel Lacalle-Fabo, Esther Martín-Bujanda, María Sarobe-Carricas, M. Teresa |
| author_facet | Fresán-Restituto, Daniel Lacalle-Fabo, Esther Martín-Bujanda, María Sarobe-Carricas, M. Teresa |
| author_sort | Fresán-Restituto, Daniel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10364061 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Viguera Editores (Evidenze Group) |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103640612023-07-25 Non-responder migraine patients to a first anti-CGRP monoclonal antibody benefit from a switch to a second one Fresán-Restituto, Daniel Lacalle-Fabo, Esther Martín-Bujanda, María Sarobe-Carricas, M. Teresa Rev Neurol Letter Viguera Editores (Evidenze Group) 2023-03-16 /pmc/articles/PMC10364061/ /pubmed/36908035 http://dx.doi.org/10.33588/rn.7606.2022350 Text en Copyright: © Revista de Neurología https://creativecommons.org/licenses/by-nc-nd/4.0/Revista de Neurología trabaja bajo una licencia Creative Commons |
| spellingShingle | Letter Fresán-Restituto, Daniel Lacalle-Fabo, Esther Martín-Bujanda, María Sarobe-Carricas, M. Teresa Non-responder migraine patients to a first anti-CGRP monoclonal antibody benefit from a switch to a second one |
| title | Non-responder migraine patients to a first anti-CGRP monoclonal antibody benefit from a switch to a second one |
| title_full | Non-responder migraine patients to a first anti-CGRP monoclonal antibody benefit from a switch to a second one |
| title_fullStr | Non-responder migraine patients to a first anti-CGRP monoclonal antibody benefit from a switch to a second one |
| title_full_unstemmed | Non-responder migraine patients to a first anti-CGRP monoclonal antibody benefit from a switch to a second one |
| title_short | Non-responder migraine patients to a first anti-CGRP monoclonal antibody benefit from a switch to a second one |
| title_sort | non-responder migraine patients to a first anti-cgrp monoclonal antibody benefit from a switch to a second one |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364061/ https://www.ncbi.nlm.nih.gov/pubmed/36908035 http://dx.doi.org/10.33588/rn.7606.2022350 |
| work_keys_str_mv | AT fresanrestitutodaniel nonrespondermigrainepatientstoafirstanticgrpmonoclonalantibodybenefitfromaswitchtoasecondone AT lacallefaboesther nonrespondermigrainepatientstoafirstanticgrpmonoclonalantibodybenefitfromaswitchtoasecondone AT martinbujandamaria nonrespondermigrainepatientstoafirstanticgrpmonoclonalantibodybenefitfromaswitchtoasecondone AT sarobecarricasmteresa nonrespondermigrainepatientstoafirstanticgrpmonoclonalantibodybenefitfromaswitchtoasecondone |